A number of doctor-prescribed drugs, like copyright and Semaglutide, are part of the GLP-1 receptor agonist class . Primarily , these medications work by mimicking the body's own hormones that regulate blood glucose and stimulate a reduction in weight . Although copyright is a brand name for managing type 2 diabetes , Semaglutide can be different

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Wegovy, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. This me